Loading…

CELLINK AB has agreed to acquire all shares of Cytena GmbH for a purchase price of EUR 30.25 million. Cytena will remain under current management post-transaction.
“The owners of Cytena GmbH have agreed to sell all Cytena shares to CELLINK AB for a purchase price of 30.25M euros.”biospace.com
Summarized from public sources; check the original articles before acting on it.